<DOC>
	<DOCNO>NCT02171494</DOCNO>
	<brief_summary>To establish bioequivalence 2x5 mg IVAX warfarin /formulation tablet vs. 10 mg Coumadin / formulation tablet</brief_summary>
	<brief_title>Bioequivalence IVAX Warfarin Tablets Coumadin Brand Warfarin Tablets Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Warfarin</mesh_term>
	<criteria>Healthy male accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( blood pressure , pulse rate , temp ) , 12lead electrocardiogram , clinical laboratory test , without clinically significant abnormal finding Age ≥ 18 Age ≤ 45 year Body Mass Index ( BMI ) ≥ 18.0 BMI ≤ 30.0 kg/m2 Signed date write informed consent prior admission study accordance GCP ( Good Clinical Practice ) local legislation A history clinically significant gastrointestinal , renal , hepatic , neurologic , hematologic , endocrine , oncologic , pulmonary , immunologic , psychiatric , cardiovascular disease condition , opinion investigator , would jeopardize safety subject impact validity study result A history allergic adverse response warfarin comparable similar product Subjects ( whatever reason ) abnormal diet substantial change eat habit within 30 day prior study initiation Subjects could make blood donation one pint within 30 day prior study initiation Subjects could make plasma donation within 14 day study initiation Participation clinical trial within 30 day prior study initiation Use overthecounter ( OTC ) medication , include vitamin , herbal product , dietary supplement , within 7 day prior study Use prescription medication within 7 day prior study Treatment know enzyme alter drug barbiturate , phenothiazine , cimetidine , carbamazepine , phenytoin , rifampin , rifabutin , glucocorticoid , diltiazem , ketoconazole , MAOI ( monoamine oxidase inhibitor ) , antidepressant , neuroleptic , verapamil , quinidine , erythromycin , etc. , within 30 day prior study Smoking use tobacco product within 6 month prior study . Smoking status verify urine cotinine screen . Female subject Positive blood screen Human Immunodeficiency Virus , Hepatitis B , Hepatitis C Positive screen alcohol , drug abuse , cotinine history presence alcoholism drug abuse within 6 month prior study start Subjects could take aspirin aspirincontaining medication antiplatelet anticoagulant medication within 7 day prior study , duration study 14 day last dose study medication aPTT ( activate partial thromboplastin time ) INR ( international normalize ratio ) result unacceptable principal investigator Inability comply dietary regimen trial site</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>